{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T22:02:18Z","timestamp":1692741738813},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.contraception.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:00:37Z","timestamp":1473764437000},"page":"223-226","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tubal contraception and ovarian cancer risk: a global view"],"prefix":"10.1016","volume":"95","author":[{"given":"Rebecca L.","family":"Callahan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Kopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Jerome F.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.09.004_bb0005","series-title":"Ovarian Cancers: Evolving Paradigms in Research and Care","author":"National Academies of Sciences, Engineering, and Medicine","year":"2016"},{"key":"10.1016\/j.contraception.2016.09.004_bb0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\"Primary peritoneal\" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0025","first-page":"296","article-title":"The role of the fallopian tube in ovarian cancer","volume":"10","author":"Tone","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","article-title":"The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer","volume":"18","author":"King","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.contraception.2016.09.004_bb0035","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2016.09.004_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00004347-200204000-00001","article-title":"Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?","volume":"21","author":"Seidman","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0045","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2016.09.004_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/aogs.12255","article-title":"The relation between endometriosis and ovarian cancer - a review","volume":"93","author":"Heidemann","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2016.09.004_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.contraception.2016.09.004_bb0060","first-page":"933","article-title":"Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"5","author":"Rosenblatt","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2016.09.004_bb0065","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2016.09.004_bb0070","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/ijc.28249","article-title":"Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case\u2013Control Study","volume":"133","author":"Rice","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2016.09.004_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.09.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.contraception.2016.09.004_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0095","author":"Society of Gynecologic Oncology"},{"key":"10.1016\/j.contraception.2016.09.004_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/AOG.0000000000001203","article-title":"Hospital Variation in the Practice of Bilateral Salpingectomy With Ovarian Conservation in 2012","volume":"127","author":"Xu","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.07.055","article-title":"Growth in salpingectomy rates in the United States since 2000","author":"Hicks-Courant","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/AOG.0000000000000422","article-title":"Female tubal sterilization: the time has come to routinely consider removal","volume":"124","author":"Creinin","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2016.09.004_bb0125","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.09.004_bb0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.contraception.2015.06.002","article-title":"Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons","volume":"92","author":"Jensen","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.09.004_bb0135","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.contraception.2013.11.017","article-title":"Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques","volume":"89","author":"Jensen","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.09.004_bb0140","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.contraception.2016.09.004_bb0145","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.contraception.2016.09.004_bb0150","series-title":"Trends in Contraceptive Use Worldwide 2015 (ST\/ESA\/SER.A\/349)","author":"United Nations, Department of Economic and Social Affairs, Population Division","year":"2015"},{"key":"10.1016\/j.contraception.2016.09.004_bb0155","author":"Ripley"},{"key":"10.1016\/j.contraception.2016.09.004_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1728-4465.2013.00345.x","article-title":"Lessons from the recent rise in use of female sterilization in Malawi","volume":"44","author":"Jacobstein","year":"2013","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.contraception.2016.09.004_bb0165","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"Alkema","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2016.09.004_bb0170","author":"World Health Organization"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416304061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416304061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:55:17Z","timestamp":1536400517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416304061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0010782416304061"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.09.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tubal contraception and ovarian cancer risk: a global view","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}